BIONIC EYE TRIAL RESULTS SHOW SUBSTANTIAL VISION IMPROVEMENTS OVER TWO AND A HALF YEARS Blind participants with retinitis pigmentosa able to locate doorways, avoid obstacles
SEGMENT
Filmed in Melbourne and Sydney | February 2025
Released on Retinitis Pigmentosa Awareness Month
INTERVIEWED
Professor James Fallon,
Chief Technology Officer Bionics Institute &
Head of the Medical Bionics Department, University of Melbourne
Associate Professor Penelope Allen,
Head of Bionic Eye Project & Principal Investigator,
Centre for Eye Research Australia (CERA) &
Vitreoretinal Surgeon,
Royal Victorian Eye and Ear Hospital
Dr Ash Attia
Chief Executive Officer & Managing Director
Bionic Vision Technologies
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Detailed outcomes from the trial, led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, were published in Ophthalmology Science.
The findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
Retinitis pigmentosa is an inherited retinal disease which affects about two million people worldwide and is one of the leading causes of vision loss in working-age people.
The bionic eye comprises an electrode array, designed by the Bionics Institute and the Centre for Eye Research Australia, that is surgically implanted behind the eye. The electrode receives signals from a video camera mounted on glasses, which stimulate the patient’s retina.
Credit: Retinitis pigmentosa fact sheet from Retina Australia
You Might also like
-
Getting the conversation going on the connection between oral health and chronic conditions
Dr. Carol Tran is an Oral Health Therapist and co-founder of Oral Health Home, an organisation focused on innovative, prevention-oriented oral health education and outreach. She is a Past President of Dental Hygienists Association of Australia (DHAA) and currently is the Scientific Program Chair, for upcoming congress in October 2025, for the newly formed Oral Health Association of Australia (OHAA).
-
Shaping Health, Advancing Nursing through training, upskilling & scholarships
The Chief Executive Officer of Australian College of Nursing, Adjunct Professor Kylie Ward FACN spoke in depth with Australian Health Journal about:
The key recommendations in ACN’s pre-budget submission to Federal Government
The impact of legislation requiring a Registered Nurse (RN) at every residential aged care facility from 1st July 2023
Why scholarships in nursing leadership are important
Why ACN has recommended the Government fund 200 Pacific nurses in 15 nations for the online ACN postgraduate certification
The need for a multi-pronged approach that includes skilled migration in rebuilding the nursing workforceIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
Paediatric mental help for children of defence personnel, veterans and first responders
Dr Marg Rogers is a Senior Lecturer in Early Childhood Education at University of New England (UNE) in Armidale, New South Wales. She is a prominent figure in early childhood education New South Wales, and is also a Post Doctoral Fellow at the Manna Institute, a mental health research organisation within the regional university network across Australia, that is building place based research capacity to improve the mental health of regional, rural and remote Australia.